The Effect of Music Therapy on Newborns
1 other identifier
interventional
42
1 country
1
Brief Summary
The clinical study is evaluating the impact of music therapy on neonates, specifically infants with neonatal opioid withdrawal syndrome (NOWS). The goal is to study the effect of music therapy on an infant's behavioral (i.e feeding patterns, sleep patterns, severity of withdrawal) and physiological systems (i.e. heart rate, respiratory rate). The investigators are also studying the impact of music therapy on the infant's utilization of resources (i.e. total opioid usage and total length of stay).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2018
CompletedFirst Submitted
Initial submission to the registry
June 6, 2019
CompletedFirst Posted
Study publicly available on registry
June 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 7, 2024
CompletedAugust 9, 2024
August 1, 2024
5.7 years
June 6, 2019
August 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in Heart Rate
Infant's heart rate before, during and after music therapy and during the control session.
Change in average heart rate over the 20 minute sessions (both control and music therapy)
Change in Heart Rate Variability
Infant's heart rate variability before, during and after music therapy and during the control session.
Change in average heart rate variability over the 20 minute sessions (both control and music therapy)
Change in Sleeping Patterns
Basic parameters of sleeping - Type of sleep during control and intervention periods, including but not limited to, active/alert, quiet alert, sleeping. We will monitor time from end of feeding to start of sleep.
Change in phase of sleep over the 20 minute sessions (both control and music therapy)
Change in Feeding Patterns
Time between the end of feeding and the onset of sleeping, with music therapy to be conducted during feeding.
Time from feeding to onset of sleep over the 20 minute session (both control and music therapy)
Morphine Utilization
Total cumulative dosage of morphine required during the infant's hospitalization as well as the total number of days on morphine. We will also determine the day of the maximum morphine dosage required by the infant.
From day of birth through day of discharge, up to 6 months
Total Length of Stay
The total number of days the infant was hospitalized, from day of birth to day of discharge from the NICU
From day of birth through day of discharge, up to 6 months
Study Arms (2)
Music Therapy
EXPERIMENTALMusic therapy by a certified music therapist will be delivered to infants over a period of 5 days. There will be two periods of data collection each day, one in the morning and one in the afternoon. Each baby will receive music therapy during one of these time points, with each baby serving as their own control during the second timepoint.
Control
NO INTERVENTIONInterventions
Music therapy will be conducted once daily using a Song of Kin, a familiar song used to lull the infant to sleep. If no Song of Kin is provided, "Twinkle Twinkle Little Star" will be the default lullaby.
Eligibility Criteria
You may qualify if:
- Admitted to the NICU or newborn nursery
- Corrected gestational age 34 weeks or older
- No identified hearing disorder
- Do not have a diagnosed developmental disability (i.e. Down Syndrome)
- Do not have Fetal Alcohol Syndrome
- Medically cleared to participate in the study
- Parent or legal guardian able/willing to give consent \& complete surveys.
You may not qualify if:
- Corrected gestational age \< 34 weeks old
- Has an identified hearing disorder
- Has diagnosed developmental disability (i.e. Down syndrome)
- Has Fetal Alcohol Syndrome
- Is not medically cleared to participate in the study
- Parent or legal guardian unable/unwilling to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tulane Lakeside Hospital - Tulane University
Metairie, Louisiana, 70001, United States
Related Publications (1)
Pahl A, Young L, Buus-Frank ME, Marcellus L, Soll R. Non-pharmacological care for opioid withdrawal in newborns. Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD013217. doi: 10.1002/14651858.CD013217.pub2.
PMID: 33348423DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meghan P Howell, MD
Tulane University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2019
First Posted
June 14, 2019
Study Start
December 10, 2018
Primary Completion
August 7, 2024
Study Completion
August 7, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share